Open AccessExcellent translational research in oncology: A journey towards novel and more effective anti‐cancer therapies
Author(s) -
Rajan A.,
Berns A.,
Ringborg U.,
Celis J.,
Ponder B.,
Caldas C.,
Livingston D.,
Bristow R.G.,
Hecht T.T.,
Tursz T.,
van Luenen H.,
Bono P.,
Helander T.,
Seamon K.,
Smyth J.F.,
Louvard D.,
Eggermont A.,
van Harten W.H.
Publication year - 2016
Publication title -
molecular oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.332
H-Index - 88
eISSN - 1878-0261
pISSN - 1574-7891
DOI - 10.1016/j.molonc.2015.12.007
Subject(s) - excellence , bench to bedside , translational research , medicine , cancer , oncology , alternative medicine , medical physics , political science , pathology , law
Comprehensive Cancer Centres (CCCs) serve as critical drivers for improving cancer survival. In Europe, we have developed an Excellence Designation System (EDS) consisting of criteria to assess “excellence” of CCCs in translational research (bench to bedside and back), with the expectation that many European CCCs will aspire to this status.